Biotech stocks yielded positive returns on Friday, November 27. The above graph compares the stock-price movements of Endo International and Mallinckrodt (MNK), its peer company, since October 2015.
- The betas for Endo International and Mallinckrodt are 1.3 and 1.5, respectively. A beta that’s more than one implies that these stocks are very sensitive to the market movement. They’re also volatile. Since Mallinckrodt’s beta is greater than Endo International’s beta, Mallinckrodt is a more sensitive stock than Endo International.
- Endo International returned 2.2% while Mallinckrodt returned 0.4% on November 27. The trailing five-day returns of the stocks are 4.9% and 10.3%, respectively. Endo International traded at $62.33. This is above its 20-day moving average but less than the 50-day and 100-day moving averages. Endo International’s 100-day, 50-day, and 20-day moving averages are $72, $63, and $58, respectively. The rise above only its 20-day moving average suggests that the stock suffered a fall in its price. Its future trend can’t be predicted. However, the stock’s target price is set at $82.60. This implies an upward potential in the stock price movement, fundamentally.
- Endo International earned 13 “buy,” eight “hold,” and no “sell” recommendations. The RSI (relative strength index) of 56 suggests that the stock isn’t oversold or overvalued. Standard & Poor’s rated the stock as “B+” with a “stable” outlook.
The stocks at the bottom of the SPDR S&P 500 ETF (SPY) on November 27 were the energy stocks—due to sell-off in the energy sector as we mentioned in Part 1 of this series. These stocks include Southwestern Energy (SWN), CONSOL Energy (CNX), and Range Resources (RRC). They yielded -7.2%, -6.5%, and -5.9%, respectively, on the day.
Next, we’ll take a look at the United Kingdom’s stock market on November 27.